APA (7th ed.) Citation

J, Y., RY, C., YJ, L., FJ, F., YJ, L., YJ, H., . . . LJ, D. (2026). Identification of EEF1A1 as a therapeutic target in TNBC: Anticancer action of a novel Penicillide-derived inhibitor through ribosomal protein regulation. Bioorganic chemistry, 172, 109602. https://doi.org/10.1016/j.bioorg.2026.109602

Chicago Style (17th ed.) Citation

J, Yu, Chen RY, Liu YJ, Feng FJ, Li YJ, Hu YJ, Yang GJ, Chen J, and Ding LJ. "Identification of EEF1A1 as a Therapeutic Target in TNBC: Anticancer Action of a Novel Penicillide-derived Inhibitor Through Ribosomal Protein Regulation." Bioorganic Chemistry 172 (2026): 109602. https://doi.org/10.1016/j.bioorg.2026.109602.

MLA (9th ed.) Citation

J, Yu, et al. "Identification of EEF1A1 as a Therapeutic Target in TNBC: Anticancer Action of a Novel Penicillide-derived Inhibitor Through Ribosomal Protein Regulation." Bioorganic Chemistry, vol. 172, 2026, p. 109602, https://doi.org/10.1016/j.bioorg.2026.109602.